Caplin Point Laboratories (NSE:CAPLIPOINT) Interest Coverage : 2,717.00 (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Caplin Point Laboratories Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Caplin Point Laboratories's Operating Income for the three months ended in Jun. 2024 was ₹1,359 Mil. Caplin Point Laboratories's Interest Expense for the three months ended in Jun. 2024 was ₹-1 Mil. Caplin Point Laboratories's interest coverage for the quarter that ended in Jun. 2024 was 2,717.00. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Caplin Point Laboratories Ltd has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Caplin Point Laboratories's Interest Coverage or its related term are showing as below:

NSE:CAPLIPOINT' s Interest Coverage Range Over the Past 10 Years
Min: 184.48 Med: 593.58 Max: 3479.13
Current: 948.42

NSE:CAPLIPOINT's Interest Coverage is ranked better than
91.88% of 665 companies
in the Drug Manufacturers industry
Industry Median: 12.26 vs NSE:CAPLIPOINT: 948.42

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Caplin Point Laboratories Interest Coverage Historical Data

The historical data trend for Caplin Point Laboratories's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Caplin Point Laboratories Interest Coverage Chart

Caplin Point Laboratories Annual Data

Trend

Jun15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Coverage

Get a 7-Day Free Trial

717.07

184.48

496.81

510.72

642.22

Caplin Point Laboratories Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Interest Coverage	Get a 7-Day Free Trial															411.25	698.00	755.18	878.40	2,717.00

Competitive Comparison of Caplin Point Laboratories's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Caplin Point Laboratories's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's Interest Coverage falls into.

Caplin Point Laboratories Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Caplin Point Laboratories's Interest Coverage for the fiscal year that ended in Mar. 2024 is calculated as

Here, for the fiscal year that ended in Mar. 2024, Caplin Point Laboratories's Interest Expense was ₹-8 Mil. Its Operating Income was ₹5,009 Mil. And its Long-Term Debt & Capital Lease Obligation was ₹9 Mil.

Interest Coverage	=	-1	*	Operating Income (A: Mar. 2024 )	/	Interest Expense (A: Mar. 2024 )
	=	-1	*	5009.3	/	-7.8
	=	642.22

Caplin Point Laboratories's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Here, for the three months ended in Jun. 2024, Caplin Point Laboratories's Interest Expense was ₹-1 Mil. Its Operating Income was ₹1,359 Mil. And its Long-Term Debt & Capital Lease Obligation was ₹0 Mil.

Interest Coverage	=	-1	*	Operating Income (Q: Jun. 2024 )	/	Interest Expense (Q: Jun. 2024 )
	=	-1	*	1358.5	/	-0.5
	=	2,717.00

The higher the ratio, the stronger the company's Financial Strength is.

Caplin Point Laboratories (NSE:CAPLIPOINT) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Caplin Point Laboratories Interest Coverage Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Caplin Point Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (NSE:CAPLIPOINT) » Definitions » Interest Coverage

Traded in Other Exchanges

524742:India

Address

Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096

Website

https://www.caplinpoint.net

Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories Headlines

No Headlines